A study identified polyphyllin VI (PPVI) as a specific agonist that activates the ROS/NF-κB/NLRP3/GSDMD signaling pathway, effectively inhibiting NSCLC by preventing cancer cell proliferation [44]. Here, NLRP3 is linked to cancer.